haem.io is building the next generation of clinical decision support tools for haematology. We're developing an AI-powered framework that navigates the complex landscape of blood cancer diagnosis and classification—transforming dense pathology reports, cytogenetics, and molecular data into clear, evidence-based diagnostic recommendations.

Our platform tackles some of the most challenging diagnostic workflows in medicine: AML/MDS classification according to WHO and ICC criteria, ELN 2022 risk stratification and treatment response assessment, MRD evaluation, and rare myeloid neoplasm identification. By combining advanced natural language processing with expert clinical logic, we're helping haematologists make faster, more accurate decisions at the point of care.

We're not replacing clinical judgment—we're augmenting it. Every classification comes with complete derivation transparency, showing exactly how we arrived at each conclusion. From initial diagnosis through treatment monitoring, haem.io serves as a tireless second opinion, ensuring no critical detail is missed in the increasingly complex world of precision haematology.

Building sophisticated medical AI that clinicians actually trust. 

Haem.io

Org chart

Teams

Offices

Haem.io

Org chart

Teams

Offices

Related companies